Compostions and methods for tissue repair
Provided herein are compositions and methods for treating a subject with damaged tissue, such as an injury associated with a tissue to tissue (e.g., a connective tissue-to-connective tissue or tissue to bone) interface. One aspect provides an adhesive film or adhesive layer, optionally comprising a biomaterial, tissue growth factors, including CTGF/CCN2, or cells.
1. A method of repairing a tissue defect at a tissue defect site comprising:
(i) providing a film or a layer;
(ii) contacting the film or the layer with an adhesive;
(iii) delivering the film or the layer to the tissue defect; and
(iv) applying the adhesive to the film, the layer, or a tissue, wherein,
the adhesive has a shear modulus (G a ) between about 10 3 and 10 10 Pa;
the adhesive has a failure shear stress value between about 10 5 Pa and about 10 7 Pa; or
the adhesive has a strain to failure value between about 3% and about 3000%;
wherein, the film or the layer at the tissue defect site increases post-surgical strength of the tissue defect; increases strength of the tissue defect; reduces post-surgical failure of the tissue defect; improves load transfer of the tissue defect; shifts the load from a few anchor points to shear along the entire film or layer, minimizing stress concentration at the tissue defect site; the tissue defect site comprises a suture and the suture and the film or the layer has an increased strength compared to the tissue defect site with no film or no layer used; or has at least about a 20% increase in strength compared to the tissue defect site with no film or no layer used.
2. The method of claim 1 , further comprising:
(i) a suture or an adhesive coated suture;
(ii) a growth factor;
(iii) a cell or cell sheet comprising a cell; or
(iv) a hydrogel or polymer.
3. The method of claim 1 , wherein
(i) a hydrogel or a polymer is a delivery agent for the adhesive, a growth factor, or a cell;
(ii) the growth factor is delivered by the hydrogel, a microsphere-based delivery system, or a fibrin-based delivery system;
(iii) the cell is seeded directly onto the film or the layer;
(iv) a suture or an anchor comprises the adhesive;
(v) the adhesive is delivered by the suture;
(vi) the growth factor comprising CTGF/CCN2 is delivered to the tissue defect site;
(vii) the cell is selected from the group consisting of: a living cell, a population of cells, a mesenchymal stromal cell, a tendon-derived stem cell, and an adipose-derived progenitor is delivered to the tissue defect site;
(viii) the hydrogel or the polymer is interspersed with the adhesive, the growth factor, or the cell; or
(ix) the adhesive is structured randomly or tailored to specify or optimize a strength, a toughness, or a stiffness of the adhesive or repair.
4. The method of claim 1 , wherein the tissue defect is selected from the group consisting of:
(i) a musculoskeletal injury, a connective tissue-to-bone defect, a connective tissue-to-connective tissue defect, a ligament-to-bone tissue defect, or a tendon-to-bone tissue defect;
(ii) a ligament/tendon-to-bone insertion, an articular cartilage-to-bone junction, a hip labrum, an intervertebral disc, a nucleus pulposus-annulus fibrosus-endplates, a cementumperiodontal ligament-alveolar bone, a muscle-to-tendon, an inhomogeneous or anisotropic tissue, a knee meniscus, a temporomandibular joint disc, a root-periodontium complex, a tendon-bone insertion, a synovial joint, or a fibrocartilaginous tissue; or
(iii) a flexor tendon, a rotator cuff, an anterior cruciate ligament, a meniscus, or an Achilles tendon.
5. The method of claim 1 , wherein
(i) the film or the layer is coated with the adhesive;
(ii) the film or the layer comprises one or more selected from the group consisting of a biocompatible film, a polymer nanofiber mesh, an ionic polymer layer, an ionic polymer film, a biodegradable polyester film, a polysaccharide-based film, a polysaccharide-based hydrogel, a polyester film, and a collagen-based matrix, a spacer material, and patterning thereof;
(iii) the adhesive is in contact with the film or the layer;
(iv) the adhesive is applied to the film or the layer, or
(v) the adhesive comprises one or more selected from the group consisting of: a catechol-based adhesive, a DOPA-based adhesive, a mechanically-based adhesive, a fibrin-based adhesive, bioglue, an ionic polymer adhesive, a biodegradable polyester adhesive, a collagen-binding adhesive, and a polysaccharide-based adhesive.
6. The method of claim 1 , wherein the shear modulus (G a ) between about 10 3 and 10 10 Pa, the failure shear stress value between about 10 5 Pa and about 10 7 Pa, or the strain to failure value between about 3% and about 3000%, identified using a shear lag model or a finite element model, results in reducing elevations of stress in a soft tissue repair.
7. The method of claim 1 , wherein the film or the layer is formed from a liquid solution applied to the tissue defect site.
8. A method of surgical repair of a tissue defect at a tissue defect site, the tissue defect comprising a first tissue and a second tissue, comprising:
(i) connecting the first tissue and the second tissue in a subject in need thereof;
(ii) implanting a film or a layer into the subject, wherein the film or the layer is implanted between the first tissue and the film or the layer comprises an adhesive; and
(iii) connecting the first tissue to the second tissue with a suture,
wherein,
the adhesive has a shear modulus (G a ) between about 10 3 and 10 10 Pa;
the adhesive has a failure shear stress value between about 10 5 Pa and about 10 7 Pa; or
the adhesive has a strain to failure value between about 3% and about 3000%,
wherein the film or the layer at the tissue defect site increases post-surgical strength of the tissue defect increases strength of the tissue defect; reduces post-surgical failure of the tissue defect; improves load transfer of the tissue defect; shifts the load from a few anchor points to shear along the entire film or layer, minimizing stress concentration at the tissue defect site; the tissue defect site comprising the suture and the film or the layer has an increased strength compared to the tissue defect site with no film or no layer used; or has at least about a 20% increase in strength compared to the tissue defect site with no film or no layer used.
9. The method of claim 8 , further comprising:
(i) a growth factor;
(ii) a cell or cell sheet comprising a cell; or
(iii) a hydrogel or polymer.
10. The method of claim 8 , wherein
(i) a hydrogel or a polymer is a delivery agent for the adhesive, a growth factor, or a cell;
(ii) the growth factor is delivered by the hydrogel, a microsphere-based delivery system, or a fibrin-based delivery system;
(iii) the cell is seeded directly onto the film or the layer;
(iv) the suture comprises the adhesive;
(v) the adhesive is delivered by the suture and wherein the suture is a porous suture;
(vi) the growth factor comprising CTGF/CCN2 is delivered to the tissue defect site;
(vii) the cell is selected from the group consisting of: a mesenchymal stromal cell, a tendon-derived stem cell, and an adipose-derived progenitor is delivered to the tissue defect site;
(viii) the hydrogel or the polymer is interspersed with the adhesive, the growth factor, or the cell; or
(ix) the adhesive is structured randomly or tailored to specify or optimize a strength, a toughness, or a stiffness of the adhesive or repair.
11. The method of claim 8 , wherein the tissue defect is selected from the group consisting of:
(i) a musculoskeletal injury, a connective tissue-to-bone defect, a connective tissue-to-connective tissue defect, a ligament-to-bone tissue defect, or a tendon-to-bone tissue defect;
(ii) a ligament/tendon-to-bone insertion, an articular cartilage-to-bone junction, a hip labrum, an intervertebral disc, a nucleus pulposus-annulus fibrosus-endplates, a cementumperiodontal ligament-alveolar bone, a muscle-to-tendon, an inhomogeneous or anisotropic tissue, a knee meniscus, a temporomandibular joint disc, a root-periodontium complex, a tendon-bone insertion, a synovial joint, or a fibrocartilaginous tissue; or
(iii) a flexor tendon, a rotator cuff, an anterior cruciate ligament, a meniscus, or an Achilles tendon.
12. The method of claim 8 , wherein
(i) the film or the layer is coated with the adhesive;
(ii) the film or the layer comprises one or more selected from the group consisting of a biocompatible film, a polymer nanofiber mesh, an ionic polymer layer, an ionic polymer film, a biodegradable polyester film, a polysaccharide-based film, a polysaccharide-based hydrogel, a polyester film, and a collagen-based matrix, a spacer material, and patterning thereof;
(iii) the adhesive is in contact with the film or the layer;
(iv) the adhesive is applied to the film or the layer;
(v) the suture comprises the adhesive; or
(vi) the adhesive comprises one or more selected from the group consisting of: a catechol-based adhesive, a DOPA-based adhesive, a mechanically-based adhesive, a fibrin-based adhesive, bioglue, an ionic polymer adhesive, a biodegradable polyester adhesive, a collagen-binding adhesive, and a polysaccharide-based adhesive.
13. The method of claim 8 , wherein the shear modulus (G a ) between about 10 3 and 10 10 Pa, failure shear stress value between about 10 5 Pa and about 10 7 Pa, or strain to failure value between about 3% and about 3000%, identified using a shear lag model or finite element model, results in reducing elevations of stress in a soft tissue repair.
14. The method of claim 8 , wherein the film or the layer is formed from a liquid solution applied to the tissue defect site.
15. A method of repairing a tissue defect at a tissue defect site comprising:
(i) providing a film or a layer;
(ii) contacting the film or the layer with an adhesive;
(iii) delivering the film or the layer to the tissue defect; and
(iv) applying the adhesive to the film, the layer, or a tissue,
wherein,
the adhesive has a shear modulus (G a ) between about 10 3 and 10 10 Pa;
the adhesive has a failure shear stress value between about 10 5 Pa and about 10 7 Pa; or
the adhesive has a strain to failure value between about 3% and about 3000%; and
the film or the layer at the tissue defect site increases post-surgical strength of the tissue defect; increases strength of the tissue defect; reduces post-surgical failure of the tissue defect; improves load transfer of the tissue defect; shifts the load from a few anchor points to shear along the entire film or layer, minimizing stress concentration at the tissue defect site; the tissue defect site comprising sutures and the film or the layer has an increased strength compared to the tissue defect site with no film or no layer used; or has at least about a 20% increase in strength compared to the tissue defect site with no film or no layer used.
16. The method of claim 15 , further comprising:
(i) a suture or an adhesive coated suture;
(ii) a growth factor;
(iii) a cell or cell sheet comprising a cell; or
(iv) a hydrogel or polymer.
17. The method of claim 15 , wherein
(i) a hydrogel or a polymer is a delivery agent for the adhesive, a growth factor, or a cell;
(ii) the growth factor is delivered by the hydrogel, a microsphere-based delivery system, or a fibrin-based delivery system;
(iii) the cell is seeded directly onto the film or the layer,
(iv) a suture or an anchor comprises the adhesive;
(v) the adhesive is delivered by the suture;
(vi) the growth factor comprising CTGF/CCN2 is delivered to the tissue defect site;
(vii) the cell is selected from the group consisting of: a living cell, a population of cells, a mesenchymal stromal cell, a tendon-derived stem cell, and an adipose-derived progenitor is delivered to the tissue defect site;
(viii) the hydrogel or the polymer is interspersed with the adhesive, the growth factor, or the cell; or
(ix) the adhesive is structured randomly or tailored to specify or optimize a strength, a toughness, or a stiffness of the adhesive or repair.
18. The method of claim 15 , wherein the tissue defect is selected from the group consisting of:
(i) a musculoskeletal injury, a connective tissue-to-bone defect, a connective tissue-to-connective tissue defect, a ligament-to-bone tissue defect, or a tendon-to-bone tissue defect;
(ii) a ligament/tendon-to-bone insertion, an articular cartilage-to-bone junction, a hip labrum, an intervertebral disc, a nucleus pulposus-annulus fibrosus-endplates, a cementumperiodontal ligament-alveolar bone, a muscle-to-tendon, an inhomogeneous or anisotropic tissue, a knee meniscus, a temporomandibular joint disc, a root-periodontium complex, a tendon-bone insertion, a synovial joint, or a fibrocartilaginous tissue; or
(iii) a flexor tendon, a rotator cuff, an anterior cruciate ligament, a meniscus, or an achilles tendon.
19. The method of claim 15 , wherein
(i) the film or the layer is coated with the adhesive;
(ii) the film or the layer comprises one or more selected from the group consisting of a biocompatible film, a polymer nanofiber mesh, an ionic polymer layer, an ionic polymer film, a biodegradable polyester film, a polysaccharide-based film, a polysaccharide-based hydrogel, a polyester film, and a collagen-based matrix, a spacer material, and patterning thereof;
(iii) the adhesive is in contact with the film or layer;
(iv) the adhesive is applied to the film or the layer; or
(v) the adhesive comprises one or more selected from the group consisting of: a catechol-based adhesive, a DOPA-based adhesive, a mechanically-based adhesive, a fibrin-based adhesive, bioglue, an ionic polymer adhesive, a biodegradable polyester adhesive, a collagen-binding adhesive, and a polysaccharide-based adhesive.
20. The method of claim 15 , wherein the film or the layer is formed from a liquid solution applied to the tissue defect site.
21. A method of surgical repair of a tissue defect at a tissue defect site, the tissue defect comprising a first tissue and a second tissue, comprising:
(i) connecting the first tissue and the second tissue in a subject in need thereof;
(ii) implanting a film or a layer into the subject, wherein the film or the layer is implanted between the first tissue and the film or the layer comprises an adhesive; and
(iii) connecting the first tissue to the second tissue with a suture, wherein,
the adhesive has a shear modulus (G a ) between about 10 3 and 10 10 Pa;
the adhesive has a failure shear stress value between about 10 5 Pa and about 10 7 Pa; or
the adhesive has a strain to failure value between about 3% and about 3000%; and
the film or the layer at the tissue defect site increases post-surgical strength of the tissue defect; increases strength of the tissue defect; reduces post-surgical failure of the tissue defect; improves load transfer of the tissue defect; shifts the load from a few anchor points to shear along the entire film or layer, minimizing stress concentration at the tissue defect site; the tissue defect site comprising the suture and the film or the layer has an increased strength compared to the tissue defect site with no film or no layer used; or has at least about a 20% increase in strength compared to the tissue defect site with no film or no layer used.
22. The method of claim 21 , further comprising:
(i) a growth factor;
(ii) a cell or cell sheet comprising a cell; or
(iii) a hydrogel or polymer.
23. The method of claim 21 , wherein
(i) a hydrogel or a polymer is a delivery agent for the adhesive, a growth factor, or a cell;
(ii) the growth factor is delivered by the hydrogel, a microsphere-based delivery system, or a fibrin-based delivery system;
(iii) the cell is seeded directly onto the film or the layer,
(iv) the suture or an anchor comprises the adhesive;
(v) the adhesive is delivered by the suture;
(vi) the growth factor comprising CTGF/CCN2 is delivered to the tissue defect site;
(vii) the cell is selected from the group consisting of: a living cell, a population of cells, a mesenchymal stromal cell, a tendon-derived stem cell, and an adipose-derived progenitor is delivered to the tissue defect site;
(viii) the hydrogel or the polymer is interspersed with the adhesive, the growth factor, or the cell; or
(ix) the adhesive is structured randomly or tailored to specify or optimize a strength, a toughness, or a stiffness of the adhesive or repair.
24. The method of claim 21 , wherein the tissue defect is selected from the group consisting of:
(i) a musculoskeletal injury, a connective tissue-to-bone defect, a connective tissue-to-connective tissue defect, a ligament-to-bone tissue defect, or a tendon-to-bone tissue defect;
(ii) a ligament/tendon-to-bone insertion, an articular cartilage-to-bone junction, a hip labrum, an intervertebral disc, a nucleus pulposus-annulus fibrosus-endplates, a cementumperiodontal ligament-alveolar bone, a muscle-to-tendon, an inhomogeneous or anisotropic tissue, a knee meniscus, a temporomandibular joint disc, a root-periodontium complex, a tendon-bone insertion, a synovial joint, or a fibrocartilaginous tissue; or
(iii) a flexor tendon, a rotator cuff, an anterior cruciate ligament, a meniscus, or an achilles tendon.
25. The method of claim 21 , wherein
(i) the film or the layer is coated with the adhesive;
(ii) the film or the layer comprises one or more selected from the group consisting of a biocompatible film, a polymer nanofiber mesh, an ionic polymer layer, an ionic polymer film, a biodegradable polyester film, a polysaccharide-based film, a polysaccharide-based hydrogel, a polyester film, and a collagen-based matrix, a spacer material, and patterning thereof;
(iii) the adhesive is in contact with the film or layer;
(iv) the adhesive is applied to the film or the layer; or
(v) the adhesive comprises one or more selected from the group consisting of: a catechol-based adhesive, a DOPA-based adhesive, a mechanically-based adhesive, a fibrin-based adhesive, bioglue, an ionic polymer adhesive, a biodegradable polyester adhesive, a collagen-binding adhesive, and a polysaccharide-based adhesive.
26. The method of claim 21 , wherein the film or the layer is formed from a liquid solution applied to the tissue defect site.